 | • レポートコード：QYR9ST02501 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のHPVワクチン市場について調査・分析し、以下の構成でお届け致します。HPVワクチンの種類別には、青少年、大人に、用途別には、男性、女性に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別HPVワクチン売上データ ・地域別HPVワクチン市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別HPVワクチン市場規模：青少年、大人 ・用途別HPVワクチン市場規模：男性、女性 ・主要メーカーの企業情報：Astellas Pharma、CSL、Emergent BioSolutions、GlaxoSmithKline、Johnson & Johnson、MedImmune、Merck、Pfizer、Sanofi Pasteur、Serum Institute ・HPVワクチンの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Human papilloma virus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus. Available vaccines protect against either two, four, or nine types of HPV. All vaccines protect against at least HPV type 16 and 18 that cause the greatest risk of cervical cancer. It is estimated that they may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and possibly some mouth cancer. They additionally prevent some genital warts with the vaccines against 4 and 9 HPV types providing greater protection.HPV vaccine is an inactivated (not live) vaccine which protects against four major types of HPV. These include two types that cause about 70% of cervical cancer and two types that cause about 90% of genital warts. HPV vaccine can prevent most genital warts and most cases of cervical cancer. Human papillomaviruses (HPVs) are a group of more than 200 related viruses. More than 40 HPV types can be easily spread through direct sexual contact, from the skin and mucous membranes of infected people to the skin and mucous membranes of their partners. They can be spread by vaginal, anal, and oral sex (1). Other HPV types are responsible for non-genital warts, which are not sexually transmitted. The segment of Female HPV vaccine market witnessed growth at a noteworthy rate over the past few years and is expected to grow in the forecast period on the back of rising awareness regarding HPV related fatal diseases, rising healthcare expenditures along with rising disposable incomes. North America and Europe accounts for the maximum market share of the global HPV vaccines market and is expected to grow at highest CAGR during the forecast period.
The global HPV Vaccines market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the HPV Vaccines market based on company, product type, end user and key regions.
This report studies the global market size of HPV Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of HPV Vaccines in these regions.
This research report categorizes the global HPV Vaccines market by top players/brands, region, type and end user. This report also studies the global HPV Vaccines market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer
Sanofi Pasteur
Serum Institute
Market size by Product
Adolescents
Adults
Market size by End User
Male
Female
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global HPV Vaccines market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of HPV Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global HPV Vaccines companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of HPV Vaccines submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of HPV Vaccines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of HPV Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 HPV Vaccines Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global HPV Vaccines Market Size Growth Rate by Product
1.4.2 Adolescents
1.4.3 Adults
1.5 Market by End User
1.5.1 Global HPV Vaccines Market Size Growth Rate by End User
1.5.2 Male
1.5.3 Female
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global HPV Vaccines Market Size
2.1.1 Global HPV Vaccines Revenue 2014-2025
2.1.2 Global HPV Vaccines Sales 2014-2025
2.2 HPV Vaccines Growth Rate by Regions
2.2.1 Global HPV Vaccines Sales by Regions
2.2.2 Global HPV Vaccines Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 HPV Vaccines Sales by Manufacturers
3.1.1 HPV Vaccines Sales by Manufacturers
3.1.2 HPV Vaccines Sales Market Share by Manufacturers
3.1.3 Global HPV Vaccines Market Concentration Ratio (CR5 and HHI)
3.2 HPV Vaccines Revenue by Manufacturers
3.2.1 HPV Vaccines Revenue by Manufacturers (2014-2019)
3.2.2 HPV Vaccines Revenue Share by Manufacturers (2014-2019)
3.3 HPV Vaccines Price by Manufacturers
3.4 HPV Vaccines Manufacturing Base Distribution, Product Types
3.4.1 HPV Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers HPV Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into HPV Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global HPV Vaccines Sales by Product
4.2 Global HPV Vaccines Revenue by Product
4.3 HPV Vaccines Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global HPV Vaccines Breakdown Data by End User
6 North America
6.1 North America HPV Vaccines by Countries
6.1.1 North America HPV Vaccines Sales by Countries
6.1.2 North America HPV Vaccines Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America HPV Vaccines by Product
6.3 North America HPV Vaccines by End User
7 Europe
7.1 Europe HPV Vaccines by Countries
7.1.1 Europe HPV Vaccines Sales by Countries
7.1.2 Europe HPV Vaccines Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe HPV Vaccines by Product
7.3 Europe HPV Vaccines by End User
8 Asia Pacific
8.1 Asia Pacific HPV Vaccines by Countries
8.1.1 Asia Pacific HPV Vaccines Sales by Countries
8.1.2 Asia Pacific HPV Vaccines Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific HPV Vaccines by Product
8.3 Asia Pacific HPV Vaccines by End User
9 Central & South America
9.1 Central & South America HPV Vaccines by Countries
9.1.1 Central & South America HPV Vaccines Sales by Countries
9.1.2 Central & South America HPV Vaccines Revenue by Countries
9.1.3 Brazil
9.2 Central & South America HPV Vaccines by Product
9.3 Central & South America HPV Vaccines by End User
10 Middle East and Africa
10.1 Middle East and Africa HPV Vaccines by Countries
10.1.1 Middle East and Africa HPV Vaccines Sales by Countries
10.1.2 Middle East and Africa HPV Vaccines Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa HPV Vaccines by Product
10.3 Middle East and Africa HPV Vaccines by End User
11 Company Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Company Business Overview
11.1.3 Astellas Pharma HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Astellas Pharma HPV Vaccines Products Offered
11.1.5 Astellas Pharma Recent Development
11.2 CSL
11.2.1 CSL Company Details
11.2.2 Company Business Overview
11.2.3 CSL HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.2.4 CSL HPV Vaccines Products Offered
11.2.5 CSL Recent Development
11.3 Emergent BioSolutions
11.3.1 Emergent BioSolutions Company Details
11.3.2 Company Business Overview
11.3.3 Emergent BioSolutions HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Emergent BioSolutions HPV Vaccines Products Offered
11.3.5 Emergent BioSolutions Recent Development
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 Company Business Overview
11.4.3 GlaxoSmithKline HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.4.4 GlaxoSmithKline HPV Vaccines Products Offered
11.4.5 GlaxoSmithKline Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Details
11.5.2 Company Business Overview
11.5.3 Johnson & Johnson HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Johnson & Johnson HPV Vaccines Products Offered
11.5.5 Johnson & Johnson Recent Development
11.6 MedImmune
11.6.1 MedImmune Company Details
11.6.2 Company Business Overview
11.6.3 MedImmune HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.6.4 MedImmune HPV Vaccines Products Offered
11.6.5 MedImmune Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Company Business Overview
11.7.3 Merck HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Merck HPV Vaccines Products Offered
11.7.5 Merck Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Pfizer HPV Vaccines Products Offered
11.8.5 Pfizer Recent Development
11.9 Sanofi Pasteur
11.9.1 Sanofi Pasteur Company Details
11.9.2 Company Business Overview
11.9.3 Sanofi Pasteur HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sanofi Pasteur HPV Vaccines Products Offered
11.9.5 Sanofi Pasteur Recent Development
11.10 Serum Institute
11.10.1 Serum Institute Company Details
11.10.2 Company Business Overview
11.10.3 Serum Institute HPV Vaccines Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Serum Institute HPV Vaccines Products Offered
11.10.5 Serum Institute Recent Development
12 Future Forecast
12.1 HPV Vaccines Market Forecast by Regions
12.1.1 Global HPV Vaccines Sales Forecast by Regions 2019-2025
12.1.2 Global HPV Vaccines Revenue Forecast by Regions 2019-2025
12.2 HPV Vaccines Market Forecast by Product
12.2.1 Global HPV Vaccines Sales Forecast by Product 2019-2025
12.2.2 Global HPV Vaccines Revenue Forecast by Product 2019-2025
12.3 HPV Vaccines Market Forecast by End User
12.4 North America HPV Vaccines Forecast
12.5 Europe HPV Vaccines Forecast
12.6 Asia Pacific HPV Vaccines Forecast
12.7 Central & South America HPV Vaccines Forecast
12.8 Middle East and Africa HPV Vaccines Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 HPV Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure HPV Vaccines Product Picture
Table HPV Vaccines Market Segments
Table Key Manufacturers HPV Vaccines Covered
Table Global HPV Vaccines Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global HPV Vaccines Sales Market Share by Product 2014-2025
Figure Adolescents Product Picture
Table Major Manufacturers of Adolescents
Figure Adults Product Picture
Table Major Manufacturers of Adults
Table Global HPV Vaccines Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Male
Figure Female
Figure HPV Vaccines Report Years Considered
Figure Global HPV Vaccines Market Size 2014-2025 (Million US$)
Figure Global HPV Vaccines Sales 2014-2025 (K MT)
Table Global HPV Vaccines Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global HPV Vaccines Sales by Regions 2014-2019 (K MT)
Table Global HPV Vaccines Sales Market Share by Regions 2014-2019
Figure Global HPV Vaccines Sales Market Share by Regions 2014-2019
Figure 2018 Global HPV Vaccines Sales Market Share by Regions
Table Global HPV Vaccines Revenue by Regions 2014-2019 (Million US$)
Table Global HPV Vaccines Revenue Market Share by Regions 2014-2019
Figure Global HPV Vaccines Revenue Market Share by Regions 2014-2019
Figure 2018 Global HPV Vaccines Revenue Market Share by Regions
Table Global HPV Vaccines Sales by Manufacturers (2014-2019) (K MT)
Table Global HPV Vaccines Sales Share by Manufacturers (2014-2019)
Figure Global HPV Vaccines Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table HPV Vaccines Revenue by Manufacturers (2014-2019) (Million USD)
Table HPV Vaccines Revenue Share by Manufacturers (2014-2019)
Figure HPV Vaccines Value Share by Manufacturers in 2018
Table Key Manufacturers HPV Vaccines Price (2014-2019) (USD/MT)
Table HPV Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers HPV Vaccines Product Type
Table Date of International Manufacturers Enter into HPV Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global HPV Vaccines Sales by Product (2014-2019) (K MT)
Table Global HPV Vaccines Sales Share by Product (2014-2019)
Figure Global HPV Vaccines Sales Market Share by Product (2014-2019)
Figure Global HPV Vaccines Sales Market Share by Product in 2018
Table Global HPV Vaccines Revenue by Product (2014-2019) (Million US$)
Table Global HPV Vaccines Revenue Share by Product (2014-2019)
Figure Global HPV Vaccines Revenue Market Share by Product (2014-2019)
Figure Global HPV Vaccines Revenue Market Share by Product in 2018
Table HPV Vaccines Price by Product 2014-2019 (USD/MT)
Table Global HPV Vaccines Sales by End User (2014-2019) (K MT)
Table Global HPV Vaccines Sales Share by End User (2014-2019)
Figure Global Sales HPV Vaccines Market Share by End User (2014-2019)
Figure Global Sales HPV Vaccines Market Share by End User in 2018
Figure North America HPV Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure North America HPV Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table North America HPV Vaccines Sales by Countries (2014-2019) (K MT)
Table North America HPV Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 North America HPV Vaccines Sales Market Share by Countries
Table North America HPV Vaccines Revenue by Countries (2014-2019) (Million US$)
Table North America HPV Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 North America HPV Vaccines Revenue Market Share by Countries
Figure United States HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure United States HPV Vaccines Revenue Growth Rate (2014-2019) (K MT)
Figure Canada HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Canada HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Mexico HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table North America HPV Vaccines Sales by Product (2014-2019) (K MT)
Table North America HPV Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 North America HPV Vaccines Market Share by Product
Table North America HPV Vaccines Sales by End User (2014-2019) (K MT)
Table North America HPV Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 North America HPV Vaccines Market Share by End User
Figure Europe HPV Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure Europe HPV Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Europe HPV Vaccines Sales by Countries (2014-2019) (K MT)
Table Europe HPV Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Europe HPV Vaccines Sales Market Share by Countries
Table Europe HPV Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Europe HPV Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe HPV Vaccines Revenue Market Share by Countries
Figure Germany HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Germany HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure France HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure France HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure UK HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure UK HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Italy HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Russia HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Europe HPV Vaccines Sales by Product (2014-2019) (K MT)
Table Europe HPV Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Europe HPV Vaccines Market Share by Product
Table Europe HPV Vaccines Sales by End User (2014-2019) (K MT)
Table Europe HPV Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Europe HPV Vaccines Market Share by End User
Figure Asia Pacific HPV Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific HPV Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific HPV Vaccines Sales by Countries (2014-2019) (K MT)
Table Asia Pacific HPV Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific HPV Vaccines Sales Market Share by Countries
Table Asia Pacific HPV Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific HPV Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific HPV Vaccines Revenue Market Share by Countries
Figure China HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure China HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Japan HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Korea HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure India HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure India HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Australia HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Philippines HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Thailand HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Singapore HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific HPV Vaccines Sales by Product (2014-2019) (K MT)
Table Asia Pacific HPV Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific HPV Vaccines Market Share by Product
Table Asia Pacific HPV Vaccines Sales by End User (2014-2019) (K MT)
Table Asia Pacific HPV Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific HPV Vaccines Market Share by End User
Figure Central & South America HPV Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America HPV Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America HPV Vaccines Sales by Countries (2014-2019) (K MT)
Table Central & South America HPV Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America HPV Vaccines Sales Market Share by Countries
Table Central & South America HPV Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Central & South America HPV Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America HPV Vaccines Revenue Market Share by Countries
Figure Brazil HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Brazil HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Argentina HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America HPV Vaccines Sales by Product (2014-2019) (K MT)
Table Central & South America HPV Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America HPV Vaccines Market Share by Product
Table Central & South America HPV Vaccines Sales by End User (2014-2019) (K MT)
Table Central & South America HPV Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America HPV Vaccines Market Share by End User
Figure Middle East and Africa HPV Vaccines Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa HPV Vaccines Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa HPV Vaccines Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa HPV Vaccines Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa HPV Vaccines Sales Market Share by Countries
Table Middle East and Africa HPV Vaccines Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa HPV Vaccines Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa HPV Vaccines Revenue Market Share by Countries
Figure GCC Countries HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Turkey HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure Egypt HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa HPV Vaccines Sales Growth Rate (2014-2019) (K MT)
Figure South Africa HPV Vaccines Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa HPV Vaccines Sales by Product (2014-2019) (K MT)
Table Middle East and Africa HPV Vaccines Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa HPV Vaccines Market Share by Product
Table Middle East and Africa HPV Vaccines Sales by End User (2014-2019) (K MT)
Table Middle East and Africa HPV Vaccines Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa HPV Vaccines Market Share by End User
Table Astellas Pharma Company Details
Table Astellas Pharma HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Astellas Pharma Recent Development
Table CSL Company Details
Table CSL HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table CSL Recent Development
Table Emergent BioSolutions Company Details
Table Emergent BioSolutions HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Emergent BioSolutions Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table MedImmune Company Details
Table MedImmune HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table MedImmune Recent Development
Table Merck Company Details
Table Merck HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Sanofi Pasteur Recent Development
Table Serum Institute Company Details
Table Serum Institute HPV Vaccines Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Serum Institute Recent Development
Table Global HPV Vaccines Sales Forecast by Regions 2019-2025 (K MT)
Table Global HPV Vaccines Sales Market Share Forecast by Regions 2019-2025
Table Global HPV Vaccines Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global HPV Vaccines Revenue Market Share Forecast by Regions 2019-2025
Table Global HPV Vaccines Sales Forecast by Product 2019-2025 (K MT)
Table Global HPV Vaccines Sales Market Share Forecast by Product 2019-2025
Table Global HPV Vaccines Revenue Forecast by Product 2019-2025 (Million US$)
Table Global HPV Vaccines Revenue Market Share Forecast by Product 2019-2025
Table Global HPV Vaccines Sales Forecast by End User 2019-2025 (K MT)
Table Global HPV Vaccines Sales Market Share Forecast by End User 2019-2025
Figure North America HPV Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America HPV Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe HPV Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe HPV Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific HPV Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific HPV Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America HPV Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America HPV Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa HPV Vaccines Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa HPV Vaccines Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table HPV Vaccines Value Chain
Table HPV Vaccines Customers List
Table HPV Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
ポリオワクチンの世界市場：インサイト・予測 Polio vaccines are vaccines used to prevent poliomyelitis (polio). Two types are used: an inactivated poliovirus given by injection (IPV) and a weakened poliovirus given by mouth (OPV). The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eli…- コンジュゲートワクチンの世界市場：インサイト・予測 Conjugate vaccines refer to those vaccines that contain bacterial capsule polysaccharide or the antigen attached or conjugated to a protein.This protein has a key role in enhancing the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against…
- 伴侶動物用ワクチンの世界市場：インサイト・予測 Companion animal vaccines are used to stimulate an immune response in pets such as canine, avian and feline. These vaccine products are of various types such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccine…
- 季節性インフルエンザワクチン治療法の世界市場：インサイト・予測 Influenza vaccine typically known as flu shot and is used for protection against influenza virus. The global Seasonal Influenza Vaccines Therapeutics market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives…
- がんワクチンの世界市場：インサイト・予測 Cancer is the second leading cause of morbidity and mortality worldwide. Major cause of cancer is gene mutation and rarely due to inherited genes. Factors such as increasing number of people with cancer, rising public awareness of vaccines, presence of promising late-stage pipeline candidates, and v…